Security
Medical Properties Trust, Inc. · MPT
MPTNYSEETFCurrentCIK 1287865Updated Nov 7, 2026
MPT price & chart
Loading TradingView…
NYSE:MPT on TradingView ↗About the company
Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world’s largest owners of hospital real estate with 365 facilities and approximately 37,000 licensed beds in nine countries and across three continents as of September 30, 2026. MPT’s financing model facilitates acquisitions and recapitalizations, and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations. For more information, please visit the Company’s website at www.mpt.com.
In the news
Securities Fraud Investigation Into Medical Properties Trust, Inc. (MPT) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm ↗
Recent filings
Show 5 more recent filings
4 filing
4 filing
Submission of Matters to a Vote of Security Holders
Items 5.07, 9.01
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q3 2023 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 14,924,195,000Source | 15,236,156,000Source | 19,004,882,000Source | 15,150,428,000Source | 16,194,743,000Source | 14,762,677,000Source | 14,853,880,000Source | 17,300,956,000Source | 15,001,775,000Source | 14,294,594,000Source | 18,304,844,000Source | 19,658,000,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 396,577,000Source | 275,616,000Source | 340,058,000Source | 509,828,000Source | 606,550,000Source | 425,001,000Source | 673,482,000Source | 224,340,000Source | 540,859,000Source | 332,335,000Source | 250,016,000Source | 235,668,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 10,262,832,000Source | 9,795,057,000Source | 10,719,465,000Source | 10,316,618,000Source | 10,001,666,000Source | 10,216,918,000Source | 10,091,802,000Source | 10,596,589,000Source | 10,394,526,000Source | 9,460,811,000Source | 10,670,979,000Source | 11,063,593,000Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 601,000Source | 600,000Source | 598,000Source | 601,000Source | 600,000Source | 598,000Source | 600,000Source | 600,000Source | 597,000Source | 600,000Source | 599,000Source | 597,000Source |
| Retained Earnings (Accumulated Deficit)USD | -4,097,973,000Source | -3,197,505,000Source | -215,058,000Source | -3,971,824,000Source | -2,348,170,000Source | -4,157,439,000Source | -3,825,178,000Source | -1,846,862,000Source | -4,136,011,000Source | -3,658,516,000Source | -971,809,000Source | 116,285,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 154,687,000Source | 57,114,000Source | -59,778,000Source | 205,768,000Source | -33,910,000Source | 123,700,000Source | -4,820,000Source | -18,838,000Source | 168,213,000Source | -94,272,000Source | 42,501,000Source | -59,184,000Source |
| Stockholders' Equity Attributable to ParentUSD | 4,660,309,000Source | 5,438,564,000Source | 8,284,530,000Source | 4,832,756,000Source | 6,190,182,000Source | 4,544,705,000Source | 4,761,024,000Source | 6,702,099,000Source | 4,606,195,000Source | 4,832,729,000Source | 7,631,600,000Source | 8,592,838,000Source |
| Additional Paid in Capital, Common StockUSD | 8,602,994,000Source | 8,578,355,000Source | 8,558,768,000Source | 8,598,211,000Source | 8,571,662,000Source | 8,577,846,000Source | 8,590,422,000Source | 8,567,199,000Source | 8,573,396,000Source | 8,584,917,000Source | 8,560,309,000Source | 8,535,140,000Source |
| Liabilities and EquityUSD | 14,924,195,000Source | 15,236,156,000Source | 19,004,882,000Source | 15,150,428,000Source | 16,194,743,000Source | 14,762,677,000Source | 14,853,880,000Source | 17,300,956,000Source | 15,001,775,000Source | 14,294,594,000Source | 18,304,844,000Source | 19,658,000,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 1,054,000Source | 2,535,000Source | 887,000Source | 1,054,000Source | 2,895,000Source | 1,054,000Source | 1,054,000Source | 2,268,000Source | 1,054,000Source | 1,054,000Source | 2,265,000Source | 1,569,000Source |
| Additional Financial Items | ||||||||||||
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 150,802,000Source | 128,721,000Source | 128,439,000Source | 291,285,000Source |
| Dividends PayableUSD | 48,419,000Source | 48,172,000Source | 90,467,000Source | 48,292,000Source | 90,336,000Source | 54,255,000Source | 48,387,000Source | 0Source | 55,351,000Source | 48,164,000Source | 92,808,000Source | 176,580,000Source |
| Long-term DebtUSD | 9,616,176,000Source | 9,215,751,000Source | 10,157,079,000Source | 9,649,035,000Source | 9,369,064,000Source | 9,662,659,000Source | 9,465,400,000Source | 10,098,723,000Source | 9,697,835,000Source | 8,848,112,000Source | 10,064,236,000Source | 10,268,412,000Source |
| Preferred Stock, Value, Issued | — | —Source | — | — | —Source | — | — | —Source | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | -77,450,000Source | -800,929,000Source | -98,068,000Source | -319,659,000Source | 33,107,000Source | -118,016,000Source | -275,937,000Source | -2,408,287,000Source | -556,092,000Source | 903,819,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 73,348,000Source | 65,431,000Source | 272,817,000Source | 453,749,000Source | 616,127,000Source | 345,577,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 573,000Source | 17,665,000Source | 25,746,000Source | 32,976,000Source | 33,250,000Source | 49,421,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 10,631,000Source | 12,989,000Source | -162,692,000Source | 29,260,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -14,259,000Source | 384,000Source | 230,767,000Source | 245,483,000Source | 505,786,000Source | 739,010,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -76,776,000Source | -89,416,000Source | -264,738,000Source | 1,318,341,000Source | 517,558,000Source | 396,056,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | — | — | — | — | 1,792,000Source | 289,000Source | 2,474,000Source | 3,805,000Source | 8,079,000Source | 29,922,000Source |
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | — | — | 23,441,000Source | — | — | 17,940,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -23,224,000Source | 426,320,000Source | 228,081,000Source | -1,479,379,000Source | -1,020,327,000Source | -1,342,523,000Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | — | — | — | — | — | — | -456,000Source | -47,142,000Source | -50,585,000Source | -127,798,000Source | 13,255,000Source | -53,612,000Source |
| Repayments of Long-term DebtUSD | — | — | — | — | — | — | 0Source | 2,252,731,000Source | 2,252,731,000Source | 701,809,000Source | 988,162,000Source | 869,606,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 20,521,000Source | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | -1,785,000Source | 4,024,000Source | 14,712,000Source | -5,224,000Source | 11,397,000Source | -12,887,000Source |
| Additional Financial Items | ||||||||||||
| Amortization of Debt Issuance Costs and DiscountsUSD | — | — | — | — | — | — | 6,983,000Source | 5,796,000Source | 26,283,000Source | 17,348,000Source | 15,775,000Source | 17,045,000Source |
| Dividends PayableUSD | — | — | 48,419,000Source | 48,172,000Source | 48,292,000Source | 90,336,000Source | 54,255,000Source | 48,387,000Source | 55,351,000Source | 48,164,000Source | 92,808,000Source | 176,580,000Source |
| Gain (Loss) on Disposition of Real Estate, Discontinued OperationsUSD | — | — | — | — | — | — | -800,000Source | 8,100,000Source | 5,500,000Source | — | — | — |
| Gains (Losses) on Sales of Investment Real EstateUSD | — | — | -9,115,000Source | 91,795,000Source | 5,212,000Source | 384,824,000Source | -790,000Source | 8,059,000Source | 5,545,000Source | 478,693,000Source | -1,815,000Source | 536,755,000Source |
| General and Administrative ExpenseUSD | — | — | 37,734,000Source | 36,625,000Source | 26,197,000Source | 35,327,000Source | 32,205,000Source | 41,911,000Source | 130,427,000Source | 133,789,000Source | 145,588,000Source | 160,494,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | — | — | 34,403,000Source | 21,643,000Source | 25,324,000Source | -401,757,000Source | 15,739,000Source | 13,986,000Source | 97,851,000Source | -366,642,000Source | 13,967,000Source | 40,800,000Source |
| Income Tax Expense (Benefit)USD | — | — | 10,872,000Source | 9,032,000Source | 9,803,000Source | 14,557,000Source | -32,822,000Source | 9,437,000Source | 38,618,000Source | 44,101,000Source | -130,679,000Source | 55,900,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -77,730,000Source | -801,163,000Source | -98,357,000Source | -320,635,000Source | 32,827,000Source | -118,275,000Source | -277,049,000Source | -2,410,271,000Source | -556,476,000Source | 902,597,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | 280,000Source | 234,000Source | 289,000Source | 976,000Source | 280,000Source | 259,000Source | 1,112,000Source | 1,984,000Source | 384,000Source | 1,222,000Source |
| Nonoperating Income (Expense)USD | — | — | -57,985,000Source | -664,987,000Source | -95,138,000Source | -325,002,000Source | -6,588,000Source | -103,059,000Source | -266,732,000Source | -2,333,208,000Source | -356,884,000Source | 315,072,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -1,498,000Source | -169,790,000Source | -124,434,000Source | -167,686,000Source | -2,505,000Source | -45,206,000Source | -172,552,000Source | -615,565,000Source | 7,586,000Source | 15,344,000Source |
| Proceeds from Issuance of Long-term DebtUSD | — | — | — | — | — | — | 0Source | 2,512,970,000Source | 2,512,970,000Source | 804,188,000Source | — | 128,536,000Source |
| Financing Receivable, Credit Loss, Expense (Reversal)USD | — | — | 85,111,000Source | 438,154,000Source | -12,659,000Source | 81,942,000Source | 14,554,000Source | 65,982,000Source | 168,186,000Source | 1,241,020,000Source | 10,194,000Source | 99,009,000Source |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 237,522,000Source | 225,827,000Source | 240,359,000Source | 266,560,000Source | 252,065,000Source | 223,799,000Source | 972,022,000Source | 995,547,000Source | 871,799,000Source | 1,542,851,000Source |
| Cost of RevenueUSD | — | — | — | — | — | — | 97,334,000Source | 81,406,000Source | 90,306,000Source | 74,165,000Source | 110,073,000Source | 167,420,000Source |
| Gross Profit (Calculated) · Derived | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Nonoperating Income (Expense)USD | — | — | -1,498,000Source | -169,790,000Source | -124,434,000Source | -167,686,000Source | -2,505,000Source | -45,206,000Source | -172,552,000Source | -615,565,000Source | 7,586,000Source | 15,344,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -66,578,000Source | -791,897,000Source | -88,265,000Source | -305,102,000Source | 285,000Source | -108,579,000Source | -237,319,000Source | -2,364,186,000Source | -686,771,000Source | 959,719,000Source |
| Income Tax Expense (Benefit)USD | — | — | 10,872,000Source | 9,032,000Source | 9,803,000Source | 14,557,000Source | -32,822,000Source | 9,437,000Source | 38,618,000Source | 44,101,000Source | -130,679,000Source | 55,900,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | 280,000Source | 234,000Source | 289,000Source | 976,000Source | 280,000Source | 259,000Source | 1,112,000Source | 1,984,000Source | 384,000Source | 1,222,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -77,730,000Source | -801,163,000Source | -98,357,000Source | -320,635,000Source | 32,827,000Source | -118,275,000Source | -277,049,000Source | -2,410,271,000Source | -556,476,000Source | 902,597,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.13Source | -1.34Source | -0.16Source | -0.54Source | 0.05Source | -0.2Source | -0.46Source | -4.02Source | -0.93Source | 1.5Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.13Source | -1.34Source | -0.16Source | -0.54Source | 0.05Source | -0.2Source | -0.46Source | -4.02Source | -0.93Source | 1.5Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 601,136,000Source | 600,229,000Source | 600,814,000Source | 600,057,000Source | 597,715,000Source | 600,594,000Source | 600,892,000Source | 600,248,000Source | 598,518,000Source | 598,634,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 601,136,000Source | 600,229,000Source | 600,814,000Source | 600,057,000Source | 597,715,000Source | 600,594,000Source | 600,892,000Source | 600,248,000Source | 598,518,000Source | 598,837,000Source |
| Additional Financial Items | ||||||||||||
| Common Stock, Dividends, Per Share, DeclaredUSD per share | — | — | 0.08Source | 0.08Source | 0.08Source | 0.3Source | 0.09Source | 0.08Source | 0.33Source | 0.46Source | 0.88Source | 1.16Source |
| Costs and ExpensesUSD | — | — | 246,115,000Source | 352,737,000Source | 233,486,000Source | 246,660,000Source | 245,192,000Source | 229,319,000Source | 942,609,000Source | 1,026,525,000Source | 1,201,686,000Source | 898,204,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 27,987,000Source | 31,112,000Source | 32,013,000Source | 26,640,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | 66,993,000Source | 204,875,000Source | 66,717,000Source | 102,240,000Source | 69,717,000Source | 64,572,000Source | 265,405,000Source | 447,657,000Source | 603,360,000Source | 332,977,000Source |
| Gains (Losses) on Sales of Investment Real EstateUSD | — | — | -9,115,000Source | 91,795,000Source | 5,212,000Source | 384,824,000Source | -790,000Source | 8,059,000Source | 5,545,000Source | 478,693,000Source | -1,815,000Source | 536,755,000Source |
| General and Administrative ExpenseUSD | — | — | 37,734,000Source | 36,625,000Source | 26,197,000Source | 35,327,000Source | 32,205,000Source | 41,911,000Source | 130,427,000Source | 133,789,000Source | 145,588,000Source | 160,494,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -219,200,000Source | -1,400,000,000Source | -144,500,000Source | 10,800,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | — | — | 34,403,000Source | 21,643,000Source | 25,324,000Source | -401,757,000Source | 15,739,000Source | 13,986,000Source | 97,851,000Source | -366,642,000Source | 13,967,000Source | 40,800,000Source |
| Interest and Other IncomeUSD | — | — | 10,172,000Source | 9,706,000Source | 12,911,000Source | 16,774,000Source | 10,285,000Source | 8,577,000Source | 43,581,000Source | 48,733,000Source | 69,177,000Source | 166,238,000Source |
| Interest ExpenseUSD | — | — | 132,395,000Source | 106,243,000Source | 129,709,000Source | 101,430,000Source | 133,330,000Source | 115,801,000Source | 510,362,000Source | 417,824,000Source | 411,171,000Source | 359,036,000Source |
| Nonoperating Income (Expense)USD | — | — | -57,985,000Source | -664,987,000Source | -95,138,000Source | -325,002,000Source | -6,588,000Source | -103,059,000Source | -266,732,000Source | -2,333,208,000Source | -356,884,000Source | 315,072,000Source |
Filing attachments
d181478dex991.htm · 8-K · 2026-10-29
Exhibit 99.1 Contact: Charles Lambert Senior Vice President of Finance & Treasurer Medical Properties Trust, Inc. (205) 397-8897 clambert@mpt.com MPT REPORTS THIRD QUARTER RESULTS Completed Previously Announced Transactions that Provided Approximately $680 Million in Asset Sale Proceeds and Significantly Extended Debt Maturities Birmingham, AL - October 29, 2026 - Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPT) today announced financial and operating results for the t…
Read attachment ↗d181478dex992.htm · 8-K · 2026-10-29
Exhibit 99.2 QUARTERLY SUPPLEMENTAL 3Q 2026 ® AT THE VERY HEART OF HEALTHCARE. On the cover and above: Centerpoint Health Community Hospital in Georgetown, Kentucky. Operated by Lifepoint Health. FORWARD-LOOKING STATEMENTS COMPANY OVERVIEW This press release includes forward-looking statements within the meaning Company Information 3 of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements can genera…
Read attachment ↗d116047dex991.htm · 8-K · 2026-04-30
EX-99.1 2 d116047dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Contact: Charles Lambert Senior Vice President of Finance & Treasurer Medical Properties Trust, Inc. (205) 397-8897 clambert@mpt.com MPT REPORTS FIRST QUARTER RESULTS Birmingham, AL - April 30, 2026 - Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPT) today announced financial and operating results for the first quarter ended March 31, 2026, as well as certain events occurring subsequent to quarter end. Net …
Read attachment ↗d116047dex992.htm · 8-K · 2026-04-30
EX-99.2 3 d116047dex992.htm EX-99.2 EX-99.2 Exhibit 99.2 QUARTERLY SUPPLEMENTAL 1Q 2026 AT THE VERY HEART OF HEALTHCARE.® QUARTERLY SUPPLEMENTAL 1Q 2026 AT THE VERY HEART OF HEALTHCARE.® [Graphic Appears Here] [Graphic Appears Here] COMPANY OVERVIEW Company Information 3 FINANCIAL INFORMATION Reconciliation of Funds from Operations 6 Debt Summary 7 Debt Maturities and Debt Metrics 8 PORTFOLIO INFORMATION Lease and Loan Maturity Schedule 9 Total Assets and Revenues by Asset Type, Operat…
Read attachment ↗d106067dex991.htm · 8-K · 2026-02-19
Exhibit 99.1 Contact: Charles Lambert Senior Vice President of Finance & Treasurer Medical Properties Trust, Inc. (205) 397-8897 clambert@mpt.com MPT REPORTS FOURTH QUARTER AND FULL-YEAR RESULTS Birmingham, AL - February 19, 2026 - Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPT) today announced financial and operating results for the fourth quarter and full-year ended December 31, 2025, as well as certain events occurring subsequent to quarter end. Net income of $0.…
Read attachment ↗d106067dex992.htm · 8-K · 2026-02-19
Exhibit 99.2 QUARTERLY SUPPLEMENTAL 4Q 2025 AT THE VERY HEART OF HEALTHCARE.® COMPANY OVERVIEW FORWARD-LOOKING STATEMENTS Company Information 3 This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements can generally be identified by the use of forward-looking words such as “may”, “will”, “would”, “could”, “expect”, “intend”, “p…
Read attachment ↗